Drug Shortage Report for IBSRELA
| Report ID | 279690 |
| Drug Identification Number | 02498049 |
| Brand name | IBSRELA |
| Common or Proper name | TENAPANOR |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | TENAPANOR |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 75 mL HDPE bottle |
| Anatomical Therapeutical Chemical (ATC) code | A06AX |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2026-03-31 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-17 |
| Company comments | Supply Interruption |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 ALEXIS-NIHON BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2026-03-09 | French | Compare |
| v9 | 2026-03-09 | English | Compare |
| v8 | 2026-03-09 | French | Compare |
| v7 | 2026-03-09 | English | Compare |
| v6 | 2026-03-04 | French | Compare |
| v5 | 2026-03-04 | English | Compare |
| v4 | 2026-03-04 | French | Compare |
| v3 | 2026-03-04 | French | Compare |
| v2 | 2026-03-04 | French | Compare |
| v1 | 2026-03-04 | English | Compare |
Showing 1 to 10 of 10